nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Acute respiratory distress syndrome—Topotecan—cervical cancer	0.0793	0.087	CcSEcCtD
Ifosfamide—Acute leukaemia—Topotecan—cervical cancer	0.0724	0.0795	CcSEcCtD
Ifosfamide—Myelosuppression—Topotecan—cervical cancer	0.0441	0.0484	CcSEcCtD
Ifosfamide—Mucosal inflammation—Topotecan—cervical cancer	0.0374	0.041	CcSEcCtD
Ifosfamide—Febrile neutropenia—Topotecan—cervical cancer	0.0344	0.0378	CcSEcCtD
Ifosfamide—Neuralgia—Topotecan—cervical cancer	0.0298	0.0327	CcSEcCtD
Ifosfamide—Interstitial lung disease—Topotecan—cervical cancer	0.0292	0.0321	CcSEcCtD
Ifosfamide—Pleural effusion—Topotecan—cervical cancer	0.027	0.0297	CcSEcCtD
Ifosfamide—Extravasation—Topotecan—cervical cancer	0.0237	0.026	CcSEcCtD
Ifosfamide—Respiratory failure—Topotecan—cervical cancer	0.0211	0.0231	CcSEcCtD
Ifosfamide—Pulmonary embolism—Topotecan—cervical cancer	0.0207	0.0227	CcSEcCtD
Ifosfamide—Colitis—Topotecan—cervical cancer	0.0199	0.0218	CcSEcCtD
Ifosfamide—Neoplasm—Topotecan—cervical cancer	0.0187	0.0205	CcSEcCtD
Ifosfamide—Sepsis—Topotecan—cervical cancer	0.018	0.0197	CcSEcCtD
Ifosfamide—Cardiac arrest—Topotecan—cervical cancer	0.0143	0.0157	CcSEcCtD
Ifosfamide—Pancytopenia—Topotecan—cervical cancer	0.0123	0.0135	CcSEcCtD
Ifosfamide—Pneumonia—Topotecan—cervical cancer	0.0116	0.0128	CcSEcCtD
Ifosfamide—Infestation NOS—Topotecan—cervical cancer	0.0116	0.0127	CcSEcCtD
Ifosfamide—Infestation—Topotecan—cervical cancer	0.0116	0.0127	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Topotecan—cervical cancer	0.0113	0.0125	CcSEcCtD
Ifosfamide—Stomatitis—Topotecan—cervical cancer	0.0113	0.0124	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Topotecan—cervical cancer	0.0109	0.012	CcSEcCtD
Ifosfamide—Haemoglobin—Topotecan—cervical cancer	0.0104	0.0115	CcSEcCtD
Ifosfamide—Haemorrhage—Topotecan—cervical cancer	0.0104	0.0114	CcSEcCtD
Ifosfamide—Angiopathy—Topotecan—cervical cancer	0.00943	0.0104	CcSEcCtD
Ifosfamide—CYP2C18—uterine cervix—cervical cancer	0.00941	0.105	CbGeAlD
Ifosfamide—Immune system disorder—Topotecan—cervical cancer	0.00938	0.0103	CcSEcCtD
Ifosfamide—Mediastinal disorder—Topotecan—cervical cancer	0.00936	0.0103	CcSEcCtD
Ifosfamide—Chills—Topotecan—cervical cancer	0.00932	0.0102	CcSEcCtD
Ifosfamide—Alopecia—Topotecan—cervical cancer	0.00918	0.0101	CcSEcCtD
Ifosfamide—Malnutrition—Topotecan—cervical cancer	0.00904	0.00993	CcSEcCtD
Ifosfamide—Ill-defined disorder—Topotecan—cervical cancer	0.00839	0.00921	CcSEcCtD
Ifosfamide—Anaemia—Topotecan—cervical cancer	0.00836	0.00918	CcSEcCtD
Ifosfamide—Angioedema—Topotecan—cervical cancer	0.00826	0.00907	CcSEcCtD
Ifosfamide—CYP2C18—mammalian vulva—cervical cancer	0.00823	0.0921	CbGeAlD
Ifosfamide—Malaise—Topotecan—cervical cancer	0.00816	0.00896	CcSEcCtD
Ifosfamide—Leukopenia—Topotecan—cervical cancer	0.0081	0.00889	CcSEcCtD
Ifosfamide—Cough—Topotecan—cervical cancer	0.00789	0.00867	CcSEcCtD
Ifosfamide—Arthralgia—Topotecan—cervical cancer	0.0077	0.00845	CcSEcCtD
Ifosfamide—Chest pain—Topotecan—cervical cancer	0.0077	0.00845	CcSEcCtD
Ifosfamide—Myalgia—Topotecan—cervical cancer	0.0077	0.00845	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00765	0.0084	CcSEcCtD
Ifosfamide—Discomfort—Topotecan—cervical cancer	0.00761	0.00835	CcSEcCtD
Ifosfamide—Anaphylactic shock—Topotecan—cervical cancer	0.00738	0.00811	CcSEcCtD
Ifosfamide—Infection—Topotecan—cervical cancer	0.00733	0.00805	CcSEcCtD
Ifosfamide—Nervous system disorder—Topotecan—cervical cancer	0.00724	0.00795	CcSEcCtD
Ifosfamide—Thrombocytopenia—Topotecan—cervical cancer	0.00723	0.00794	CcSEcCtD
Ifosfamide—Skin disorder—Topotecan—cervical cancer	0.00717	0.00787	CcSEcCtD
Ifosfamide—Hyperhidrosis—Topotecan—cervical cancer	0.00714	0.00784	CcSEcCtD
Ifosfamide—Anorexia—Topotecan—cervical cancer	0.00704	0.00773	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00672	0.00738	CcSEcCtD
Ifosfamide—Paraesthesia—Topotecan—cervical cancer	0.00663	0.00728	CcSEcCtD
Ifosfamide—Dyspnoea—Topotecan—cervical cancer	0.00658	0.00723	CcSEcCtD
Ifosfamide—Decreased appetite—Topotecan—cervical cancer	0.00642	0.00705	CcSEcCtD
Ifosfamide—CYP2C18—vagina—cervical cancer	0.00637	0.0714	CbGeAlD
Ifosfamide—Gastrointestinal disorder—Topotecan—cervical cancer	0.00637	0.007	CcSEcCtD
Ifosfamide—Fatigue—Topotecan—cervical cancer	0.00636	0.00699	CcSEcCtD
Ifosfamide—Pain—Topotecan—cervical cancer	0.00631	0.00693	CcSEcCtD
Ifosfamide—Constipation—Topotecan—cervical cancer	0.00631	0.00693	CcSEcCtD
Ifosfamide—Feeling abnormal—Topotecan—cervical cancer	0.00608	0.00668	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Topotecan—cervical cancer	0.00604	0.00663	CcSEcCtD
Ifosfamide—Urticaria—Topotecan—cervical cancer	0.00586	0.00644	CcSEcCtD
Ifosfamide—Body temperature increased—Topotecan—cervical cancer	0.00584	0.00641	CcSEcCtD
Ifosfamide—Abdominal pain—Topotecan—cervical cancer	0.00584	0.00641	CcSEcCtD
Ifosfamide—Hypersensitivity—Topotecan—cervical cancer	0.00544	0.00597	CcSEcCtD
Ifosfamide—Asthenia—Topotecan—cervical cancer	0.0053	0.00582	CcSEcCtD
Ifosfamide—Pruritus—Topotecan—cervical cancer	0.00522	0.00573	CcSEcCtD
Ifosfamide—Diarrhoea—Topotecan—cervical cancer	0.00505	0.00555	CcSEcCtD
Ifosfamide—Dizziness—Topotecan—cervical cancer	0.00488	0.00536	CcSEcCtD
Ifosfamide—Vomiting—Topotecan—cervical cancer	0.00469	0.00515	CcSEcCtD
Ifosfamide—Rash—Topotecan—cervical cancer	0.00465	0.00511	CcSEcCtD
Ifosfamide—Dermatitis—Topotecan—cervical cancer	0.00465	0.00511	CcSEcCtD
Ifosfamide—Nausea—Topotecan—cervical cancer	0.00438	0.00481	CcSEcCtD
Ifosfamide—CYP2A6—vagina—cervical cancer	0.00421	0.0472	CbGeAlD
Ifosfamide—CYP2C8—renal system—cervical cancer	0.00326	0.0365	CbGeAlD
Ifosfamide—CYP2C8—endometrium—cervical cancer	0.00316	0.0353	CbGeAlD
Ifosfamide—CYP3A5—uterine cervix—cervical cancer	0.00315	0.0353	CbGeAlD
Ifosfamide—CYP3A5—renal system—cervical cancer	0.00295	0.033	CbGeAlD
Ifosfamide—CYP2B6—renal system—cervical cancer	0.00293	0.0328	CbGeAlD
Ifosfamide—PTGS1—epithelium—cervical cancer	0.00285	0.032	CbGeAlD
Ifosfamide—PTGS1—uterine cervix—cervical cancer	0.00283	0.0317	CbGeAlD
Ifosfamide—CYP2C19—vagina—cervical cancer	0.00271	0.0303	CbGeAlD
Ifosfamide—PTGS1—renal system—cervical cancer	0.00265	0.0296	CbGeAlD
Ifosfamide—CYP2C8—female reproductive system—cervical cancer	0.00261	0.0293	CbGeAlD
Ifosfamide—PTGS1—endometrium—cervical cancer	0.00256	0.0287	CbGeAlD
Ifosfamide—PTGS1—mammalian vulva—cervical cancer	0.00248	0.0277	CbGeAlD
Ifosfamide—CYP2C8—vagina—cervical cancer	0.00236	0.0265	CbGeAlD
Ifosfamide—PTGS1—uterus—cervical cancer	0.00236	0.0264	CbGeAlD
Ifosfamide—CYP2B6—female reproductive system—cervical cancer	0.00235	0.0263	CbGeAlD
Ifosfamide—CYP2C9—female reproductive system—cervical cancer	0.00232	0.026	CbGeAlD
Ifosfamide—CYP3A4—renal system—cervical cancer	0.00221	0.0248	CbGeAlD
Ifosfamide—CYP3A5—female gonad—cervical cancer	0.00215	0.024	CbGeAlD
Ifosfamide—CYP3A5—vagina—cervical cancer	0.00213	0.0239	CbGeAlD
Ifosfamide—CYP2B6—vagina—cervical cancer	0.00212	0.0237	CbGeAlD
Ifosfamide—PTGS1—female reproductive system—cervical cancer	0.00212	0.0237	CbGeAlD
Ifosfamide—PTGS1—female gonad—cervical cancer	0.00193	0.0216	CbGeAlD
Ifosfamide—PTGS1—vagina—cervical cancer	0.00192	0.0215	CbGeAlD
Ifosfamide—CYP3A4—female reproductive system—cervical cancer	0.00177	0.0198	CbGeAlD
Ifosfamide—PTGS1—lymph node—cervical cancer	0.00124	0.0139	CbGeAlD
